13D Filing: Baker Bros. Advisors Owns 18% of Bellicum Pharmaceuticals, Inc (BLCM)

Page 2 of 9 SEC Filing

  

CUSIP No.  079481107 Page   2   of  9   Pages

1.

NAMES OF REPORTING PERSONS

Baker Bros. Advisors LP

2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)  ¨
(b)  ¨
3.

SEC USE ONLY

4.

SOURCE OF FUNDS*

OO

5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) or 2(e)
      ¨
6.

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
7. SOLE VOTING POWER 4,865,647
8. SHARED VOTING POWER:  0
9. SOLE DISPOSITIVE POWER:  4,865,647
10. SHARED DISPOSITIVE POWER:  0
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: 4,865,647
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (See Instructions)
   ¨
13.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

18.0% (1)

14.

TYPE OF REPORTING PERSON (See Instructions)

IA, PN

(1) Based on 26,998,423 shares of common stock outstanding as
of January 12, 2016, as reported in the Issuer’s Form S-3 filed with the SEC on January 15, 2016.

Follow Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)